THE EFFECT OF GENDER ON REVERSAL OF NONDEPOLARIZING BLOCK

1 Kayseri Training and Research Hospital, Anesthesiology and Reanimation Clinics, Kayseri, Turkey 2 Ankara Numune Training and Research Hospital, Anesthesiology and Reanimation Clinics, Ankara, Turkey 3 Bülent Ecevit University, Faculty of Medicine, Department of Anesthesiology and Reanimation, Zonguldak, Turkey 4 Dokuz Eylül University, Faculty of Medicine, Department of Anesthesiology and Reanimation, İzmir, Turkey 5 Bartın State Hospital Anesthesiology and Reanimation Clinics, Bartın, Turkey 6 Ortaköy State Hospital Anesthesiology and Reanimation Clinics, Aksaray, Turkey 7 Sakarya University, Faculty of Medicine, Department of Anesthesiology and Reanimation Adapazarı, Turkey

[1]  I. Kurt,et al.  The incidence of residual neuromuscular blockade associated with single dose of intermediate-acting neuromuscular blocking drugs. , 2012, Middle East journal of anaesthesiology.

[2]  L. Hrabálek,et al.  Influence of age and gender on the pharmacodynamic parameters of rocuronium during total intravenous anesthesia. , 2011, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[3]  M. Murakawa,et al.  Reversal of vecuronium with neostigmine: a comparison between male and female patients. , 2009, Fukushima journal of medical science.

[4]  D. Mattison,et al.  Sex Differences in Pharmacokinetics and Pharmacodynamics , 2009, Clinical pharmacokinetics.

[5]  D. Hepner,et al.  Neuromuscular blockade, reversal agent use, and operating room time: retrospective analysis of US inpatient surgeries. , 2009, Current medical research and opinion.

[6]  M. Adamus,et al.  Influence of gender on the course of neuromuscular block following a single bolus dose of cisatracurium or rocuronium , 2008, European journal of anaesthesiology.

[7]  C. Hong,et al.  Postoperative residual curarization: clinical observation in the post-anesthesia care unit. , 2008, Chang Gung medical journal.

[8]  M. Adamus,et al.  Influence of gender on the onset and duration of rocuronium-induced neuromuscular block. , 2007, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[9]  J. Leikin,et al.  NEUROMUSCULAR-BLOCKING AGENTS , 2007 .

[10]  B. Sweeney,et al.  Recovery from neuromuscular blockade: a survey of practice. , 2006, Anaesthesia.

[11]  G. Cammu.  Postoperative residual curarisation: complication or malpractice? , 2004, Acta anaesthesiologica Belgica.

[12]  B. Plaud,et al.  Residual Paralysis in the PACU after a Single Intubating Dose of Nondepolarizing Muscle Relaxant with an Intermediate Duration of Action , 2003, Anesthesiology.

[13]  E. Kharasch,et al.  Gender differences in drug effects: implications for anesthesiologists , 2003, Acta anaesthesiologica Scandinavica.

[14]  D. Bevan.  Neuromuscular blockade. Inadvertent extubation of the partially paralyzed patient. , 2001, Anesthesiology clinics of North America.

[15]  R. Mirakhur,et al.  Neostigmine antagonism of rocuronium block during anesthesia with sevoflurance, isoflurane or propofol , 2001, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[16]  T. Fuchs-Buder,et al.  [Time course of neuromuscular blockade after rocuronium. A comparison between women and men]. , 2000, Der Anaesthesist.

[17]  F. Xue,et al.  Dose-response curve and time-course of effect of vecuronium in male and female patients. , 1998, British journal of anaesthesia.

[18]  F. Xue,et al.  The Pharmacokinetics of Vecuronium in Male and Female Patients , 1998, Anesthesia and analgesia.

[19]  F. Xue,et al.  Dose-Response and Time Course of Effect of Rocuronium in Male and Female Anesthetized Patients , 1997, Anesthesia and analgesia.

[20]  S. Brull.  Indicators of recovery of neuromuscular function: time for change? , 1997, Anesthesiology.

[21]  W. Buzello,et al.  Muscle relaxants: a clinical update. , 1996, Acta anaesthesiologica Scandinavica. Supplementum.

[22]  Ronald D. Miller,et al.  The Pharmacokinetics and Neuromuscular Effects of Rocuronium Bromide in Patients with Liver Disease , 1995, Anesthesia and analgesia.

[23]  G. Shorten.  Postoperative Residual Curarisation: Incidence, Aetiology and Associated Morbidity , 1993, Anaesthesia and intensive care.

[24]  J. Wierda,et al.  Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (Org 9426) during isoflurane anaesthesia in patients with and without renal failure. , 1993, British journal of anaesthesia.